FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. AAPL
2. BRZE
3. TTAN
4. CHYM
5. USO
6. COO
7. IRT
8. QCOM
9. AEO
10. MSI

Go back to FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA
Asianada, Inc. (NASDAQ: ASND) Delayed: 260.81 -9.28 (3.44%)
Previous Close $270.09    52 Week High $21.79 
Open $270.89    52 Week Low $11.92 
Day High $272.37    P/E N/A 
Day Low $260.75    EPS $-0.07 
Volume 497,432